$11.48
+0.46 (+4.20%)
Open$10.65
Previous Close$11.02
Day High$11.48
Day Low$10.00
52W High$18.20
52W Low$2.88
Volume—
Avg Volume21.6K
Market Cap27.49M
P/E Ratio—
EPS$-5.64
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.61M | 10.68M | 9.55M |
| Net Income | 789.2K | 807.9K | 770.6K |
| Profit Margin | 7.4% | 7.6% | 8.1% |
| EBITDA | 1.40M | 1.47M | 1.23M |
| Free Cash Flow | 547.8K | 770.2K | 737.4K |
| Rev Growth | -2.0% | +19.5% | +10.5% |
| Debt/Equity | 0.36 | 0.38 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |